The Best Medicines Coalition (BMC) is a national alliance of patient organizations, together representing millions of patients, with a shared goal of equitable, timely and consistent access to safe and effective medicines that improve patient outcomes.
On March 26, the BMC issued a submission to the Federal Government on its consultation on high-cost drugs for rare diseases. The CHS, which is a BMC member, has been an active contributor in drafting this submission.
CLICK HERE to access the submission.
